tiprankstipranks
Viking Therapeutics (VKTX)
NASDAQ:VKTX
US Market
VKTX
Viking Therapeutics
RESEARCH TOOLSreports
Want to see VKTX full AI Analyst Report?

Viking Therapeutics (VKTX) Income Statement

7,421 Followers

Viking Therapeutics Income Statement

Last quarter (Q1 2026), Viking Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Viking Therapeutics's net income was $-158.32M. See Viking Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -431.00K$ 0.00$ -292.00K$ 0.00$ 0.00
Operating Expenses
$ 393.34M$ 150.92M$ 100.83M$ 70.36M$ 55.68M
Depreciation and Amortization
$ 431.00K$ 346.00K$ 292.00K$ 291.00K$ 296.00K
EBITDA
$ -393.34M$ -150.57M$ -100.53M$ -70.06M$ -55.39M
Operating Income
$ -393.34M$ -150.92M$ -100.83M$ -70.36M$ -55.68M
Other Income/Expenses
$ 33.70M$ 40.96M$ 14.93M$ 1.49M$ 692.00K
Pretax Income
$ -359.64M$ -109.96M$ -85.89M$ -68.87M$ -54.99M
Net Income
$ -359.64M$ -109.96M$ -85.89M$ -68.87M$ -54.99M
Per Share Metrics
Basic EPS
$ -3.19$ -1.01$ -0.91$ -0.88$ -0.70
Diluted EPS
$ -3.19$ -1.01$ -0.91$ -0.88$ -0.70
Weighted Average Shares Outstanding
 112.67M 109.04M 94.35M 76.83M 77.20M
Weighted Average Shares Outstanding (Diluted)
 112.67M 109.04M 94.35M 76.83M 77.20M
Currency in USD

Viking Therapeutics Earnings and Revenue History